COGENT BIOSCIENCES INC (COGT)
US19240Q2012 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 53.23M | 139.90M | 219.70M | 242.20M | 37.40M | |||
| Marketable Securities | 212.48M | 119.40M | N/A | N/A | 0.00 | |||
| Receivables | N/A | N/A | N/A | 0.00 | 2.00M | |||
| Other Current Assets | 5.06M | 5.70M | 2.90M | 2.70M | 1.20M | |||
| Total Current Assets | 270.77M | 265.00M | 222.60M | 244.90M | 40.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 30.34M | 31.10M | 4.50M | 4.70M | 7.20M | |||
| Investments And Advances | 7.46M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 4.86M | 4.70M | 5.00M | 1.30M | 1.70M | |||
| Total Non-Current Assets | 42.67M | 35.80M | 9.50M | 6.00M | 8.80M | |||
| TOTAL ASSETS | 313.44M | 300.80M | 232.10M | 250.90M | 49.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 27.07M | 18.90M | 10.30M | 5.80M | 7.90M | |||
| Accounts Payable | 10.65M | 5.80M | 3.50M | 700.00K | 3.20M | |||
| Other Current Liabilities | 441.00K | 2.10M | 3.30M | 6.50M | 2.20M | |||
| Total Current Liabilities | 38.17M | 26.80M | 17.10M | 13.10M | 13.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 17.47M | 18.20M | 800.00K | 3.20M | 4.40M | |||
| Total Non-Current Liabilities | 17.47M | 18.30M | 800.00K | 3.10M | 4.50M | |||
| TOTAL LIABILITIES | 55.63M | 45.10M | 17.90M | 16.20M | 17.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -603.62M | -411.20M | -271.00M | -198.70M | -123.90M | |||
| Additional Paid In Capital | 801.06M | 601.20M | 399.70M | 322.50M | 155.60M | |||
| Common Shares | 60.12M | 65.90M | 85.40M | 110.90M | 0.00 | |||
| Other Shareholders' Equity | 246.00K | -100.00K | N/A | N/A | 0.00 | |||
| Shares Outstanding | 86.12M | 69.90M | 43.80M | 32.30M | 7.70M | |||
| Tangible Book Value per Share | 2.30 | 2.72 | 2.94 | 3.83 | 4.13 | |||
| Total Shareholders' Equity | 257.80M | 255.70M | 214.20M | 234.70M | 31.80M | |||
| TOTAL LIABILITIES AND EQUITY | 313.44M | 300.80M | 232.10M | 250.90M | 49.40M | |||
| Statistics | ||||||||
| Current Ratio | 7.09 | 9.89 | 13.02 | 18.69 | 3.08 | |||
| Return On Assets (ROA) | -61.39% | -46.62% | -31.14% | -71.43% | -64.43% | |||
| Return On Equity (ROE) | -74.63% | -54.85% | -33.74% | -76.36% | -100.09% | |||
All data in USD